* USANA Health Sciences Inc USNA.N USNA.K is expected
to show
a fall in quarterly revenue when it reports results on February
25 for the period ending December 31 2024
* The Salt Lake City Utah-based company is expected to
report a
5.5% decrease in revenue to $208.844 million from $221.08
million a year ago, according to the mean estimate from 2
analysts, based on LSEG data.
* LSEG's mean analyst estimate for USANA Health Sciences
Inc is
for earnings of 49 cents per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for USANA
Health
Sciences Inc is $51.50, above its last closing price
of $32.09.
This summary was machine generated February 21 at 21:34 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)